Healthcare DIVE October 10, 2022
Dive Brief:
- About 51% of Medicare Advantage plans offering prescription drug coverage in 2023 will have four or more stars, down from 68% of plans in 2022, CMS said in a press release.
- The decline reflects the unusual circumstance of nearly all plans qualifying for a regulatory adjustment for extreme and uncontrollable circumstances last year due to COVID-19, resulting in higher-than-normal star ratings distributions, the agency said.
- The annual rankings are designed to help beneficiaries compare the quality of Medicare Advantage and Medicare Part D prescription drug plans ahead of the open enrollment period, which runs from Oct. 15 through Dec. 7. Plans are ranked on a scale of one to five stars that beneficiaries can see through Medicare.gov. ...
Today's Sponsors
Today's Sponsor